Unicycive

01/05/2026

We’re entering the new year with a renewed commitment to transforming . Our Senior Director of Insights and Analytics, Anne Marie Schauman, shares more about what continues to push our team forward in innovating for the kidney disease community.

12/17/2025

Collaborating with such a passionate and talented group of individuals makes our mission even more rewarding. Together, our Unicycive team is committed to advancing healthcare and delivering therapies that truly make a difference. Hear more from Anne Marie Schauman and Mitchell Freidberg.

12/11/2025

Current treatments to manage pose a range of challenges that can impact patients’ quality of life.

Pablo Pergola discusses difficulties faced when treating this condition and how we are committed to addressing it.

11/26/2025

Get to know Anne Marie Schauman, our Senior Director of Insights and Analytics. Hear how she tackles challenges on the job and her thoughts on the superior college basketball team (hint: North Carolina).

11/13/2025

November is National Family Caregivers Month. Caregivers play invaluable roles in supporting loved ones living with chronic kidney disease. Join us in recognizing their unwavering commitment and expressing our gratitude for their tireless work.

11/07/2025

Yesterday at we presented results for our investigational phosphate binder for patients with chronic kidney disease (CKD). The findings showed significant reductions in both pill volume and pill burden for CKD patients with hyperphosphatemia. Learn more about our key findings and what it could mean for patients who struggle to improve phosphate control: https://unicycive.com/oxylanthanum-carbonate-achieves-serum-phosphate-control-with-significantly-lower-pill-burden-in-dialysis-patients-with-hyperphosphatemia/

11/07/2025

Yesterday at we presented results for our investigational phosphate binder for patients with chronic kidney disease (CKD). The findings showed significant reductions in both pill volume and pill burden for CKD patients with hyperphosphatemia. Learn more about our key findings and what it could mean for patients who struggle to improve phosphate control: https://unicycive.com/oxylanthanum-carbonate-achieves-serum-phosphate-control-with-significantly-lower-pill-burden-in-dialysis-patients-with-hyperphosphatemia/

10/27/2025

Unicycive’s investigational phosphate binder has the potential to shift the treatment paradigm for individuals with chronic kidney disease on dialysis who struggle to manage hyperphosphatemia.

Dr. Pablo Pergola, the principal investigator of our pivotal Phase 2 clinical trial, explains how.

Discover more about the study results, recently published in the Clinical Journal of the American Society of Nephrology: https://unicycive.com/resource-library/

10/23/2025

We're thrilled to partner with Life Science Cares Bay Area to support Family House. It was a "spook-tacular" day assembling Halloween-themed STEM kits! 👻

A huge thank you to Unicycive Therapeutics for partnering with Life Science Cares to support Family House. Their team assembled 1,500 Halloween-themed STEM kits for youth: Pumpkin Catapult, Halloween Bouncy Ball, and Glow-in-the-Dark Slime. jack_o_lantern sparkles

These kits bring hands-on learning and a bit of seasonal fun to children staying at Family House, a home away from home for families with children facing serious medical conditions.

What an incredible afternoon kicking off our holiday season of giving. Thank you for your commitment to STEM learning and for uplifting children and families in our community.

10/22/2025

We’re committed to advancing a solution that enhances phosphate control while reducing pill size and count, boosting adherence and empowering those on dialysis to manage their treatment more effectively. Learn more about our lead asset’s potential: https://unicycive.com/olc/

10/09/2025

Meet Mitchell Freidberg, our VP of Commercial Business Operations. From shark enthusiast to shoe collector, get to know Mitch and hear his habits for success.

09/12/2025

We’re looking forward to attending the Renal Healthcare Association Annual Conference and learning important insights from members of the chronic kidney disease community. Come visit us at Booth 118.